| Main |

To reduce hospitals’ COVID-19 overcrowding, the Biden Admin. encourages antibody treatment after testing positive, to prevent symptomatic stage!

https://newswirenews.com/wp-content/uploads/2021/08/merlin_193159569_81ddf555-a291-45d9-b4c0-404b376247da-facebookJumbo.jpg
Credit: The New York Times

  • Editor’s note: Finally, after plenty of monoclonal antibodies have been stored by the U. S. government, hospital systems on the verge of collapse due to COVID-19 overcrowding, are finally giving them a go and mainstream media is covering this story!
  • These are the same monoclonal antibodies used in the multiple drug cocktail to save the life of President Trump and may keep many from having to go to the hospital.

MONOCLONAL ANTIBODIES NOW ENCOURAGED BY BIDEN ADMIN.

+ Vanderbilt University Medical Center: U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC [April 6, 2021]

+ The Rachel Maddow Show on MSNBC: Feds aim to save Covid-flooded hospitals with antibody therapy facility

+ The New York Times: As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments – A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.

+ Association of American Physicians and Surgeons: Peter McCullough, MD testifies to Texas Senate HHS Committee – Doctors need to treat their COVID-19 patients and if so, an 85% reduction of hospitalizations would ensue. [Ed. note: Dr. McCullough says doctors sending positive tested patients home to wait for symptoms is not TREATING them, which they took an oath to do! Monoclonal antibodies is one of the treatments administered along with an anti-inflammatory, Vit. C & D, and zinc.]

+ Journal of Infection: Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

+ Wall Street Journal: Why Is the FDA Attacking a Safe, Effective Drug? Ivermectin is a promising Covid treatment and prophylaxis, but the agency is denigrating it.

+ University of Oxford (UK): Ivermectin to be investigated as a possible treatment for COVID-19 in Oxford’s PRINCIPLE trial

+ Truthout: TX Governor Gets Rare COVID Treatment While Banning Mask and Vaccine Mandates [monoclonal antibody treatment!]

+ The Washington Post: Monoclonal antibodies are a freely available treatment for covid-19 that can prevent severe disease if given early enough to patients. Donald Trump, when he became sick as president, received them. But patients are rarely taking this therapy now. Fewer than 30 percent of eligible patients have taken Regeneron Pharmaceuticals’ monoclonal antibodies, the drug company said. “It is absolutely the standard of care for covid-19,” one infectious-disease pharmacist told The Post. “It is my hope that clinics know that.” Source

Posted by Steve on August 20, 2021 at 12:31 am | Permalink

Post a comment

No comments yet. You should be kind and add one!

By submitting a comment you grant Yelm Community Blog a perpetual license to reproduce your words and name/web site in attribution. Inappropriate and irrelevant comments will be removed at an admin’s discretion. Your email is used for verification purposes only, it will never be shared.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Categories

Archives

Social Media Auto Publish Powered By : XYZScripts.com